By Vincent Couey, RxGrab founder. Source-cited from CMS, HHS, and FTC primary documents. Updated .
A pharmacy benefit manager denial feels final at the counter, but it almost never is. The denial notice is the opening move in a structured process with defined levels, deadlines, and a federally backed right to an independent review. Most people give up at the first no, which is exactly what makes appeals worth filing: the success rates for appeals that actually get submitted are meaningfully higher than the share of patients who bother to submit them. This guide walks the whole path, with the cash-bridge tactic that keeps you medicated while it runs.
If your denial was really a price problem in disguise, a denial because the cash price beats your copay, start with our insurance vs cash price guide instead, and run the drug through the RxGrab pharmacy finder to see the cash number.
A pharmacy benefit manager (PBM) is the company that runs your prescription benefit on behalf of your insurer or employer, and it denies prescriptions to control cost and steer utilization. The three largest, CVS Caremark, Express Scripts, and OptumRx, process the majority of U.S. prescription claims, and a January 2025 Federal Trade Commission (FTC) report detailed how their formulary and reimbursement decisions shape what you can get and what you pay.[1] Your first clue to a denial is usually the EOB or the pharmacy reject message itself.
The denial usually takes one of a few forms: the drug is off-formulary, it requires prior authorization (PA) you have not obtained, you are subject to step therapy, or you hit a quantity limit. Each of these is appealable. The U.S. Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) set the appeal framework that every plan must follow.[2]
No. A denial means your plan will not pay for it on the current terms, not that you cannot get the drug. You can appeal the coverage decision and, separately, buy the drug cash in the meantime, which are two different tracks you can run at once.
Every category of PBM denial is appealable, and naming yours correctly sets the right appeal path. The four common types each have a standard rebuttal your prescriber can supply.
| Denial type | What it means | The winning rebuttal |
|---|---|---|
| Off-formulary | Drug is not on the plan's covered list | Formulary exception: covered alternatives are ineffective or contraindicated |
| Prior authorization | Pre-approval required and not yet obtained | Prescriber submits PA with diagnosis and clinical criteria met |
| Step therapy | Must try cheaper drugs first | Step-therapy exception: documented prior trial-and-failure of the required steps |
| Quantity limit | Plan caps the amount per fill or period | Quantity-limit exception with dosing rationale from the prescriber |
The common thread is that the prescriber, not you, supplies the clinical justification, while you drive the paperwork and deadlines. Your job is to make the doctor's office act quickly and to file the written appeal on time.
An appeal is a five-step sequence, and following the order keeps you inside every deadline. Do not skip the exception request; it is often faster than a full appeal.
Appeal deadlines are set by your plan type and printed on the denial notice, so the notice is your single source of truth. As general benchmarks, Medicare Part D gives you 60 days to request a redetermination, and commercial plans commonly allow 60 to 180 days for an internal appeal.[3] Expedited appeals are decided within 72 hours when a delay would seriously jeopardize your health.
A formulary exception asks the plan to cover a drug that is off its list or to waive a step-therapy or quantity restriction, based on your prescriber's clinical justification. It is frequently the fastest route to a yes because it goes straight to the medical-necessity question instead of arguing process. The prescriber states the diagnosis, the covered alternatives that failed or are contraindicated, and why this specific drug is required.
For Medicare enrollees, CMS publishes the coverage-determination and exception process in detail, and the same logic applies to most commercial plans.[3] If your denial involves a high-cost specialty drug, our Medicare Part D cost guide covers how the tiers and the catastrophic phase change what an approval is worth.
The prescriber supplies the clinical statement, but you can initiate and track it. Call the office, request the exception by name, and follow up every business day, because doctor-office inertia is the most common avoidable delay.
A winning appeal is built on documented medical necessity, not on how strongly you feel about the drug. The reviewers are looking for a specific, defensible clinical case, so the appeals that succeed share a few traits you can deliberately supply. The strongest single factor is a clear record that the plan's preferred alternatives were already tried and failed, were contraindicated, or are expected to be ineffective for your particular situation.
Three concrete moves lift your odds. First, get the prescriber to write a detailed letter of medical necessity that names the diagnosis, the alternatives ruled out, and the clinical evidence for your drug. Second, attach supporting records, chart notes, prior fill history, and any relevant lab results, rather than asserting facts without proof. Third, cite the plan's own coverage criteria back to it; if the formulary policy lists exception conditions and you meet one, say so explicitly. The Centers for Medicare and Medicaid Services publishes the standards reviewers apply, which your prescriber's office can mirror in the letter.[2]
It can. For state-regulated plans, your state department of insurance can clarify your external-review rights and sometimes intervene. It is a useful escalation when a plan is slow-walking a clearly meritorious appeal.
The cash-bridge tactic keeps you on your medication during the appeal so a coverage fight never becomes a treatment gap. Because a discount card is a cash transaction independent of your plan, you can fill the drug at the cash or coupon price while the appeal is pending, then switch back to coverage once it is approved. This is the single most useful practical move in the whole process.
For high-cost drugs where even the cash price is out of reach, manufacturer and nonprofit assistance can cover the gap. Our patient assistance programs guide lays out who qualifies and how to apply, and it pairs naturally with an active appeal.
If you are self-employed, the medication you pay for out of pocket during an appeal can count toward a medical expense deduction once you clear the AGI threshold, and an HSA pays for it pre-tax. Our network partner CeoCult covers the medical expense deduction in full.
Yes. Every plan must offer an internal appeal and, if that fails, an independent external review. Start with a formulary exception or prior authorization from your prescriber, file a written internal appeal within the deadline on the notice, then escalate to external review if needed.
Deadlines vary by plan but are stated on the denial notice. For Medicare Part D you generally have 60 days to request a redetermination. Commercial plans commonly allow 60 to 180 days. Expedited appeals for urgent cases are decided within 72 hours.
A formulary exception asks the plan to cover a drug not on its formulary, or to waive step therapy or a quantity limit, based on your prescriber's clinical justification. It is usually the fastest path to reversing a denial when a covered alternative does not work for you.
Request an expedited appeal, which must be decided within 72 hours when a delay would seriously jeopardize your health. In the meantime, compare the cash price with a discount card or transparent pharmacy, since a cash fill can bridge the gap while the appeal runs.